Order Article Reprints

Puthanakit T, Chantasrisawad N, Yoohat K, Nantanee R, Sophonphan J, Meepuksom T, Sodsai P, Phanthanawiboon S, Jantarabenjakul W, Hirankarn N, et al. Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents. Vaccines. 2022; 10(10):1646. https://doi.org/10.3390/vaccines10101646

Puthanakit, Thanyawee, Napaporn Chantasrisawad, Kirana Yoohat, Rapisa Nantanee, Jiratchaya Sophonphan, Thutsanun Meepuksom, Pimpayao Sodsai, Supranee Phanthanawiboon, Watsamon Jantarabenjakul, Nattiya Hirankarn, and et al. 2022. "Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents" Vaccines 10, no. 10: 1646. https://doi.org/10.3390/vaccines10101646

Puthanakit, T., Chantasrisawad, N., Yoohat, K., Nantanee, R., Sophonphan, J., Meepuksom, T., Sodsai, P., Phanthanawiboon, S., Jantarabenjakul, W., Hirankarn, N., & Kosalaraksa, P. (2022). Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents. Vaccines, 10(10), 1646. https://doi.org/10.3390/vaccines10101646